Stephan Spahn
Impact in
- Hepatology top 1%
- Hepatocellular Carcinoma Treatment and Prognosis
- Hepatitis C virus research
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers
Papers in
-
- Uterine Myomas and Treatments 2
- Pregnancy and preeclampsia studies 2
-
- Hepatocellular Carcinoma Treatment and Prognosis 3
- Co-authors
- Franz Bahlmann (9 shared papers)Marcus Alexander Mall (1 shared paper)Johanna J. Salomon (1 shared paper)Joachim Füllekrug (1 shared paper)Xiao-hui Wang (1 shared paper)Carol A. Bertrand (1 shared paper)Marius Horger (2 shared papers)Nisar P. Malek (3 shared papers)
- Journals
- Archives of Gynecology and Obstetrics (1 paper)American Journal of Physiology-Lung Cellular and Molecular Physiology (1 paper)Liver International (1 paper)Frontiers in Oncology (1 paper)npj Precision Oncology (1 paper)
- Partner nations
- GermanySwitzerlandAustria
In The Last Decade
Stephan Spahn
15 papers receiving 1.4k citations
Stephan Spahn's Hit Papers
Peers
Comparison fields: 5 of 63
- Hepatology 642
- Oncology 328
- Epidemiology 378
- Cancer Research 158
- Immunology 168
Countries citing papers authored by Stephan Spahn
This map shows the geographic impact of Stephan Spahn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephan Spahn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephan Spahn more than expected).
Fields of papers citing papers by Stephan Spahn
This network shows the impact of papers produced by Stephan Spahn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephan Spahn. The network helps show where Stephan Spahn may publish in the future.
Co-authors
The 25 scholars most cited alongside Stephan Spahn, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | NASH limits anti-tumour surveillance in immunotherapy-treated HCC Hit paper breakdown → | 2021 | 1006 |
| 2 | Prognosis of patients with hepatocellular carcinoma treated with immunotherapy – development and validation of the CRAFITY score Hit paper breakdown → | 2021 | 226 |
| 3 | 2020 | 60 | |
| 4 | 2016 | 37 | |
| 5 | 2022 | 28 | |
| 6 | 2013 | 20 | |
| 7 | 2011 | 16 | |
| 8 | 2024 | 15 | |
| 9 | 2021 | 13 | |
| 10 | 2021 | 2 | |
| 11 | 2025 | 2 | |
| 12 | 2024 | 2 | |
| 13 | 2022 | 1 | |
| 14 | 2017 | 1 | |
| 15 | 2005 | 1 | |
| 16 | 2020 | 0 | |
| 17 | 2021 | 0 | |
| 18 | 2025 | 0 | |
| 19 | 2019 | 0 | |
| 20 | 2026 | 0 |
About Stephan Spahn
Stephan Spahn is a scholar working on Obstetrics and Gynecology, Hepatology, Rheumatology, Oncology and Molecular Biology, having authored 21 papers that have together received 1.4k indexed citations. Recurring topics across this work include Fibroblast Growth Factor Research (4 papers), Hepatocellular Carcinoma Treatment and Prognosis (3 papers), Cancer Immunotherapy and Biomarkers (3 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (3 papers), IgG4-Related and Inflammatory Diseases (3 papers), Uterine Myomas and Treatments (2 papers), Pregnancy and preeclampsia studies (2 papers) and Tumors and Oncological Cases (2 papers). The work is most often cited by research in Hepatology (642 citations), Oncology (328 citations), Epidemiology (378 citations), Cancer Research (158 citations) and Immunology (168 citations). Stephan Spahn has collaborated with scholars based in Germany, Switzerland and Austria. Frequent co-authors include Franz Bahlmann, Marcus Alexander Mall, Johanna J. Salomon, Joachim Füllekrug, Xiao-hui Wang, Carol A. Bertrand, Marius Horger, Nisar P. Malek, Michael Bitzer and Jean‐François Dufour. Their work appears in journals such as Archives of Gynecology and Obstetrics, American Journal of Physiology-Lung Cellular and Molecular Physiology, Liver International, Frontiers in Oncology and npj Precision Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.